[ad_1]
US President Donald Trump continued with its protectionism policy. This time he is with the vaccines, reported AP.
The agency notes that Donald Trump has signed a decree that prioritizes the supply of vaccine in the United States over its export.
The news came after a meeting at the White House, which was attended by Donald Trump himself.
Updated
In the United States with prior approval of the Pfizer / BioNtech vaccine
The US agency is expected to make a final decision on the vaccine in a few days.
AFP recalls that Donald Trump promised to guarantee for April of next year vaccine for all Americans.
The population of the United States is more than 330 million people.
So far, it is known that Pfizer – Biontech has a contract with the United States for 100 million doses. “Modern” also promised 100 million doses.
Moderna said the vaccine has been shown to be effective across all ages, races, ethnicities, and genders, as well as 100 percent successful in preventing severe cases of the disease, which has killed nearly 1.5 million people.
New record of infected with COVID-19 in the United States
2607 died in one day
The meeting of the US regulator, in which the application for registration of the “Moderna” vaccine will be considered, is scheduled for December 17th.
The Donald Trump administration has allocated $ 486 million to Moderna to develop a vaccine. The Johnson & Johnson pharmaceutical company received $ 456 million and AstraZeneca, which is developing a vaccine with scientists at the University of Oxford, received $ 1.2 billion.
The US administration has invested in these projects a total of $ 12 billion.
[ad_2]
